Pål-Dag Line

Professor

Norway

Research Interests

Explore related searches

Professors in Norway

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Pål-Dag Line is a Professor at the Institute of Clinical Medicine in Norway. His research primarily focuses on liver transplantation, colorectal metastases, and cancer treatment methodologies. Recent articles highlight his work on novel transplant approaches for challenging cancers and the outcomes of surgical interventions in borderline resectable pancreatic cancer. Professor Line is recognized for his contributions to understanding the role of liver transplantation in oncology.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (4)

Caroline Verbeke

Prof. Dr.

University of Oslo

NORWAY

View details

Roberto Hernandez-Alejandro

University of Rochester Medical Center

UNITED STATES

View details

Sheraz Yaqub

Associate Professor of Surgery

University of Oslo

NORWAY

View details

Espen Melum

Oslo University Hospital

NORWAY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Pål-Dag Line

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Liver transplantation for colorectal metastases following hepatic resection

A Novel Transplant Approach for Locally Advanced Unresectable Perihilar Cholangiocarcinoma

Surgical, Histopathological, and Quality of Life Outcomes Following Neoadjuvant Chemotherapy and Pancreatectomy for Borderline Resectable and Locally Advanced Pancreatic Cancer

Liver transplantation as a treatment for cancer: comprehensive review

Gaza War: Too many citizens being killed

Reply to A. Jain et al

Emerging Role of Liver Transplantation for Unresectable Colorectal Liver Metastases

Festina lente—to advance we need to make haste slowly. Living donor liver transplant for colorectal cancer liver metastases

Cyclosporine vs. tacrolimus after liver transplantation for primary sclerosing cholangitis – a propensity score-matched intention-to-treat analysis

Long-term survival after liver transplantation in patients with common variable immunodeficiency

AN EXPERIENCE ON LIVING DONOR LIVER TRANSPLANTATION FOR COLORECTAL LIVER METASTASIS IN SOUTH AMERICA: A NEW ERA IN TRANSPLANT ONCOLOGY

Metabolic Tumor Volume from 18F-FDG PET/CT in Combination with Radiologic Measurements to Predict Long-Term Survival Following Transplantation for Colorectal Liver Metastases

PET-Uptake in Liver Metastases as Method to Predict Tumor Biological Behavior in Patients Transplanted for Colorectal Liver Metastases Developing Lung Recurrence

Survival after liver resection and liver transplantation for colorectal liver metastases: a comparative analysis stratified by metabolic tumor volume assessed by 18F-FDG PET/CT

Cost-effectiveness of liver transplantation versus last-resort systemic therapy for colorectal liver metastases

Selection criteria in liver transplantation for hepatocellular carcinoma: an ongoing evolution

Early detection of anastomotic leakage after pancreatoduodenectomy with microdialysis catheters: an observational Study

Evaluation and Management of Liver Transplant Candidates with Prior Nonhepatic Cancer: Guidelines from the ILTS/SETH Consensus Conference

Health-Related Quality of Life in Colorectal Cancer Patients Treated With Liver Transplantation Compared to Chemotherapy

Impaired Neurocognitive Performance in Children after Liver Transplantation

Collaborators (4)

Caroline Verbeke

Roberto Hernandez-Alejandro

Sheraz Yaqub

Espen Melum

Make your next move.